Theartarium Champions Everyday Ayurveda: Simple Lifestyle Changes for Better Health
In today's fast-moving world, did you ever sit back to ponder how our grandparents lived - with simplicity, balance, and a deep connection to nature?
And do you know the secret behind such a fulfilling lifestyle? It was all their daily habits that were deeply rooted in Ayurveda, the ancient Indian science of wellness. And guess what? Those habits are making a comeback for all the right reasons.
If you've been feeling a little off-balance lately - maybe tired, sluggish, or just overwhelmed - maybe it's time for you to adapt bits of the Ayurvedic wellness routine. But don't worry, you
won't need to completely overhaul your lifestyle to feel better. Sometimes, all it takes is a few small, mindful changes because that's exactly what Ayurvedic living is about - making simple, natural swaps that align your body and mind.
So, here are some easy Ayurvedic-inspired habits you can bring into your modern lifestyle, starting today.
1. Start Your Day with a Copper Bottle Ritual
Let's begin with the simplest (and most refreshing) change: switch your regular plastic water bottle for a pure copper water bottle
But why copper?
According to Ayurveda, storing water in a copper vessel overnight purifies the water naturally and infuses it with many powerful nutrients. And drinking copper-infused water first thing in the morning can help balance the three doshas of your body (Vata, Pitta, and Kapha) that, in turn, improve digestion and support your immune system.
All you have to do is fill your copper bottle at night, let it sit overnight, and drink from it the next morning on an empty stomach. This ancient practice, known as 'Tamra Jal,' is still one of the easiest wellness habits you can adopt.
Not to mention, copper bottles are durable, eco-friendly, and look beautiful with that sheer golden finish. More so, a 1-litre copper bottle is a perfect size to carry around and stay hydrated throughout the day while reaping all those ancient health benefits.
2. Upgrade Your Cookware
Another effortless way to adapt to Ayurvedic living is by switching up your cookware. If you love making chapatis, dosas, or parathas, consider investing in a brass tawa.
Brass is a traditional metal used in Indian kitchens for generations. It heats evenly, holds warmth longer, and is believed to retain more nutrients during cooking. But the best part is that,
unlike modern non-stick pans that can wear out or release chemicals over time, brasscookware is completely natural and long-lasting.
And if you are anywhere worried about the cost, then know that the brass tawa price is quite reasonable, especially considering how durable and health-friendly it is.
3. Sip Warm Water with Spices in the Morning
Instead of reaching for coffee or tea the moment you wake up, try something that's gentle on your gut, like a glass of warm water with a pinch of turmeric, ginger, or cumin. These simple spices are Ayurvedic powerhouses and work beautifully to awaken your digestive system.
Turmeric reduces inflammation, ginger boosts metabolism, and cumin supports digestion. Just one small cup of this warm infusion in the morning can do wonders for how your body feels throughout the day.
4. Tune in to Natural Rhythms
Ayurveda mainly emphasizes the importance of aligning your daily habits with natural rhythms, meaning waking up with the sun, eating meals on time, and sleeping before 10 PM.
This might sound basic, but in a world where late-night scrolling and skipping meals are the norm, these simple habits can help you feel more balanced and calm.
You can start with waking up just 15 - 30 minutes earlier than usual and see how it changes your mood and energy levels. A quiet, peaceful morning sets the tone for a better day.
5. Eat Fresh, Seasonal, and Homemade Food
It is rightly said - You're what you eat! Hence, be mindful of what you feed your body.
Herein, the key is to eat foods that are fresh, seasonal, and cooked with love. Homemade meals are always better than processed ones, and your body knows the difference.
You can start with small changes: cook at home more often, use whole ingredients, and avoid cold, processed, or leftover food as much as you can. The more real your food, the more real your energy.
Takeaway
Living an Ayurvedic lifestyle doesn't mean giving up your modern comforts. It simply means finding balance, and sometimes, the best place to start is with small, meaningful swaps.
Something as easy as drinking from a copper bottle, cooking with traditional utensils, or making time for a calming morning ritual can truly shift how you feel.
You don't need to be perfect. You just need to start. Ayurveda isn't about pressure - it's about presence. And once you begin to tune into your body, you'll be surprised at how much it's been waiting for you to listen.
Media Contact
Company Name: Theartarium
Contact Person: Michael Thompson
Email: Send Email
City: New York
Country: United States
Website: https://theartarium.com/
Press Release Distributed by ABNewswire.com
To view the original version on ABNewswire visit: Theartarium Champions Everyday Ayurveda: Simple Lifestyle Changes for Better Health

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
4 hours ago
- Yahoo
From September, Singapore mandates measles shots for helpers in homes with unvaccinated kids
SINGAPORE, June 11 — From September 1, all domestic helpers in Singapore working in homes with children under the age of seven who are not fully vaccinated against measles must themselves be immunised, the country's Ministry of Manpower (MOM) announced yesterday. The move is aimed at safeguarding 'unvaccinated young children who are at higher risk of serious health complications from measles infections', said MOM, as reported by Channel News Asia (CNA). Singapore has already recorded 10 measles infections in 2025 as of the week ending May 10, just one shy of the total 11 cases reported in all of 2024, according to the Ministry of Health. Employers applying for or renewing work permits for migrant domestic workers (MDWs) must now declare: Whether the domestic helper is already vaccinated or immune to measles Whether all children under seven in the household are fully vaccinated If unvaccinated, whether a vaccination appointment has been booked Domestic helpers may be exempted if they are already immune — either through previous infection or past vaccination — or if all children under seven in the home have been fully immunised. Proof of immunity, such as vaccination records or serology test results, may be required. Employers are advised to check their domestic helper's immunity status well before permit renewal. Households with immunocompromised members are also strongly encouraged to verify their helper's measles immunity or arrange for vaccination. To meet the requirement, domestic helpers must receive two doses of the MMR (measles, mumps, and rubella) vaccine, spaced at least 28 days apart. The vaccine is available at private GP clinics, with the cost to be paid by employers. MOM also warned against false declarations. 'If employers with children below seven years old are found with MDWs who are not immune against measles, their work pass privileges may be suspended until vaccination proof is submitted,' the ministry said. Random checks and documentary audits will be conducted to ensure compliance. While Singapore maintains high overall vaccination rates — over 95 per cent for the first MMR dose and 90 per cent for the second among resident two-year-olds — sporadic cases are expected, MOM said, citing the 'highly transmissible nature of the disease'. The Communicable Diseases Agency (CDA) stressed that despite strong local immunity, 'the surge in measles cases globally and regionally continues to pose public health risks, particularly for those without measles immunity'. Measles, which spreads through airborne droplets, has been part of Singapore's compulsory childhood immunisation schedule since 1985.
Yahoo
4 hours ago
- Yahoo
Kelun-Biotech Announces Breakthrough Therapy Designation Granted for Sacituzumab Tirumotecan (Sac-TMT) in Combination With Tagitanlimab in China for Certain Types of Non-Small Cell Lung Cancer
CHENGDU, China, June 10, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") today announced that its TROP2-directed antibody-drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT) (佳泰莱®) in combination with the PD-L1 monoclonal antibody tagitanlimab (科泰莱®) was granted Breakthrough Therapy Designation by the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) of China for the first-line treatment of locally advanced or metastatic non-squamous non-small cell lung cancer (NSCLC) without actionable genomic alterations. Breakthrough Therapy Designation is granted for treatment options that demonstrate significant clinical advantages over currently available treatments and is aimed at expediting the research, development and marketing of innovative treatment options that address clinically urgent medical needs. This designation is based on the efficacy and safety data from the non-squamous cohort of the Phase II OptiTROP-Lung01 study. This marks the fifth Breakthrough Therapy Designation granted to sac-TMT by the NMPA. Sac-TMT has previously received this designation for: Locally advanced or metastatic triple-negative breast cancer (TNBC) in July 2022; EGFR-mutant, locally advanced or metastatic NSCLC after progression on EGFR-TKI therapy in January 2023; Locally advanced or metastatic hormone-receptor positive (HR+) and human epidermal growth factor receptor 2-negative (HER2-) breast cancer (BC) in patients who have previously received at least two lines of systemic chemotherapy in June 2023; First-line treatment of unresectable locally advanced, recurrent or metastatic PD-L1 negative TNBC in March 2024. Results from a Phase 2 OptiTROP-Lung01 study of sac-TMT in combination with tagitanlimab in first-line advanced or metastatic non-squamous NSCLC patients were presented in a poster session at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting[1]. Dr. Michael Ge, CEO of Kelun-Biotech said, "This designation by the NMPA highlights the importance of developing novel therapeutic options for diverse NSCLC subtypes. Sac-TMT in combination with tagitanlimab demonstrated clinically meaningful outcomes in key endpoints for patients with non-squamous NSCLC without actionable genomic alterations as a first-line treatment. We are excited about the therapeutic potential of TROP2 ADC- immunotherapy combinations, and we look forward to working with regulatory authorities in China to bring this combination therapy to patients in need as soon as possible." [1] Abstract #8529: Lung Cancer – Non-Small Cell Metastatic, ASCO Annual Meeting, 2025 About sac-TMT (佳泰莱®)Sac-TMT, a core product of the Company, is a novel human TROP2 ADC in which the Company has proprietary intellectual property rights, targeting advanced solid tumors such as NSCLC, BC, gastric cancer (GC), gynecological tumors, among others. Sac-TMT is developed with a novel linker to conjugate the payload, a belotecan-derivative topoisomerase I inhibitor with a drug-to-antibody-ratio (DAR) of 7.4. Sac-TMT specifically recognizes TROP2 on the surface of tumor cells by recombinant anti-TROP2 humanized monoclonal antibodies, which is then endocytosed by tumor cells and releases KL610023 intracellularly. KL610023, as a topoisomerase I inhibitor, induces DNA damage to tumor cells, which in turn leads to cell-cycle arrest and apoptosis. In addition, it also releases KL610023 in the tumor microenvironment. Given that KL610023 is membrane permeable, it can enable a bystander effect, or in other words kill adjacent tumor cells. In May 2022, the Company licensed the exclusive rights to MSD (the tradename of Merck & Co., Inc., Rahway, NJ, USA) to develop, use, manufacture and commercialize sac-TMT in all territories outside of Greater China (includes Mainland China, Hong Kong, Macao, and Taiwan). To date, two indications for sac-TMT have been approved and marketed in China for the treatment of adult patients with unresectable locally advanced or metastatic TNBC who have received at least two prior systemic therapies (at least one of them for advanced or metastatic setting) and EGFR mutation-positive locally advanced or metastatic non-squamous NSCLC following progression on EGFR-TKI therapy and platinum-based chemotherapy. Sac-TMT became the first domestic ADC with global intellectual property rights to be fully approved for marketing. It is also the world's first TROP2 ADC to be approved for marketing in a lung cancer indication. In addition, two new indication applications for sac-TMT for the treatment of adult patients with EGFR-mutant locally advanced or metastatic NSCLC who progressed after treatment with EGFR-TKI therapy and with unresectable locally advanced, metastatic HR+/HER2- BC who have received prior endocrine therapy and other systemic treatments in the advanced or metastatic setting were accepted by the CDE, and were included in the priority review and approval process. As of today, the Company has initiated 8 registrational clinical studies in China. MSD has initiated 14 ongoing Phase 3 global clinical studies of sac-TMT as a monotherapy or with pembrolizumab2 or other agents for several types of cancer. These studies are sponsored and led by MSD. About Tagitanlimab (科泰莱®)Tagitanlimab is the first PD-L1 mAb globally to receive authorization for the first-line treatment of NPC. Previously, the NMPA has approved the marketing in China of tagitanlimab used in combination with cisplatin and gemcitabine for the first-line treatment of patients with R/M NPC and monotherapy for the treatment of patients with recurrent or metastatic NPC who have failed after prior 2L+ chemotherapy, respectively. About Kelun-BiotechKelun-Biotech ( is a holding subsidiary of Kelun Pharmaceutical ( which focuses on the R&D, manufacturing, commercialization and global collaboration of innovative biological drugs and small molecule drugs. The company focuses on major disease areas such as solid tumors, autoimmune, inflammatory, and metabolic diseases, and in establishing a globalized drug development and industrialization platform to address the unmet medical needs in China and the rest of world. The Company is committed to becoming a leading global enterprise in the field of innovative drugs. At present, the Company has more than 30 ongoing key innovative drug projects, of which 3 projects have been approved for marketing, 1 project is in the NDA stage, and more than 10 projects are in the clinical stage. The company has established one of the world's leading proprietary ADC platforms, OptiDC™, and has 1 ADC project approved for marketing, 1 ADC project in NDA stage, and multiple ADC and novel DC assets in clinical or preclinical research stage. For more information, please visit Media: klbio_pr@ View original content to download multimedia: SOURCE Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Yahoo
5 hours ago
- Yahoo
Stiff, Tired, and Gaining Weight After 40? Pilates Fitness Offers a Smarter Way to Stay Strong in Mid-Life
Pilates Fitness introduces a structured, science-informed fitness and recovery system that is tailored for adults over 40 SINGAPORE, June 11, 2025 /PRNewswire/ -- With Singapore's population ageing rapidly, more adults in their 40s and beyond grapple with reduced mobility, persistent fatigue, and chronic joint pain. A leading Pilates Singapore studio with over 15 years of providing Reformer Pilates classes, Pilates Fitness offers a new three-part training and recovery framework designed to help adults maintain strength, prevent injury, and extend functional independence well into later life. "As we age, the ability to recover and maintain strength with mobility becomes more important than intensity or aesthetics," said Candice Chin, founder of Pilates Fitness. "At Pilates Fitness, we've developed a system grounded in science to meet those needs, focusing on long-term health rather than short-term trends." A Science-Based, Systematic Approach to Active Ageing Pilates Fitness' method integrates three essential components: 1) Smart Class Design Each Reformer Pilates class is structured to address specific goals. The studio offers three primary class types: Core Pilates for injury recovery and beginners, Flexi Stretch Pilates to improve joint mobility and ease muscle tightness, and Weight Loss Pilates for clients focused on fat management. This empowers adults over 40 to train with intention, adapting to their body's evolving needs. Its science-backed approach effectively addresses menopause-related weight gain, chronic joint pain, age-related stiffness, and injury prevention. 2) Individualised Attention in Group Settings Instructors deliver hands-on guidance to every participant to ensure correct muscle activation, even in small group classes of up to 10 people. Specialised adjustments are made for clients managing conditions like slipped discs, joint limitations, post-surgery recovery, or perimenopause. Chin says, "It's the benefit of private instruction within a communal setting." 3) Recovery as a Core Component Recognising the importance of rest in overall health, the studio incorporates designated recovery days featuring BIXEPS Pro — a patented magnetic mitohormesis therapy developed by the National University of Singapore and ETH Zurich. Members use the BIXEPS Pro therapy on designated rest days to promote cellular regeneration, reduce inflammation, and support metabolic health by stimulating mitochondria, the body's energy producer. A recent article in The Straits Times highlighted the growing use of magnetic pulse therapy to support muscle strength and prevent frailty in older adults. Pilates Fitness is among the first fitness studios in Singapore to integrate the higher-intensity Pro version into client routines. Results Rooted in Experience Scientific studies on Reformer Pilates have shown its effectiveness in improving balance, muscle strength, and posture and reducing fall risk among older adults. Pilates Fitness' approach aligns with this evidence and with client feedback. Jocelyn Foo, 52, had considered surgery after years of chronic knee pain. "After joining Pilates Fitness and incorporating BIXEPS Pro into my recovery, my pain began to ease. I feel stronger and have regained my confidence in daily movement," she said. The Pilates studio has worked with over 16,000 clients since 2010, with more than 65% attending weekly sessions for over five years. Many train alongside spouses, children, or parents, making Pilates Fitness a multigenerational wellness space. Supporting Healthspan, Not Just Lifespan Pilates Fitness focuses on helping clients stay active and independent as they age. "Our clients want to travel, care for their families, and stay mobile into their 80s and 90s," said Chin. "That's what we mean when we say healthspan — not just living longer but living better." Experience the Difference Pilates Fitness is running a "Bring a Loved One for Free" promotion in June to encourage shared wellness among families and friends. For more information, visit and follow on: Facebook: @PilatesFitness Instagram: @sgpilatesfitness YouTube: @PilatesFitnessFam About Pilates Fitness At Pilates Fitness, we blend scientific precision with genuine care. Since 2010, we have helped over 16,000 clients reclaim their strength, mobility, and confidence through our science-backed proprietary Reformer Pilates methodology enhanced by BIXEPS Pro therapy. As one of Singapore's pioneer Pilates studios, we specialize in helping adults over 40 move better and live stronger. Our instructors don't just correct form - they ensure proper muscle activation for real results. Combined with BIXEPS Pro therapy for intentional rest, our clients experience reduced inflammation and accelerated recovery. We're a multi-generational studio where over 65% of members have trained with us for more than five years, with 78% training alongside their partners, children, parents, or grandparents. View original content: SOURCE Pilates Fitness Pte Ltd Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data